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Abstract
Background: Plasmodium requires an obligatory life stage in its mosquito host. The parasites encounter a number of insults
while journeying through this host and have developed mechanisms to avoid host defenses. Lysozymes are a family of
important antimicrobial immune effectors produced by mosquitoes in response to microbial challenge.
Methodology/Principal Findings: A mosquito lysozyme was identified as a protective agonist for Plasmodium.
Immunohistochemical analyses demonstrated that Anopheles gambiae lysozyme c-1 binds to oocysts of Plasmodium
berghei and Plasmodium falciparum at 2 and 5 days after infection. Similar results were observed with Anopheles stephensi
and P. falciparum, suggesting wide occurrence of this phenomenon across parasite and vector species. Lysozyme c-1 did not
bind to cultured ookinetes nor did recombinant lysozyme c-1 affect ookinete viability. dsRNA-mediated silencing of LYSC-1
in Anopheles gambiae significantly reduced the intensity and the prevalence of Plasmodium berghei infection. We conclude
that this host antibacterial protein directly interacts with and facilitates development of Plasmodium oocysts within the
mosquito.
Conclusions/Significance: This work identifies mosquito lysozyme c-1 as a positive mediator of Plasmodium development
as its reduction reduces parasite load in the mosquito host. These findings improve our understanding of parasite
development and provide a novel target to interrupt parasite transmission to human hosts.
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Introduction
Plasmodium parasites, the etiologic agents of malaria, display a
complex life cycle with multiple forms occurring in the vertebrate
and invertebrate hosts. In the mosquito, parasites undergo sexual
reproduction and develop through several stages within the gut
before transforming into mobile ookinetes that cross the gut
epithelium. The ookinetes reach the basal lamina surrounding the
gut and then transform into oocysts. The oocyst undergoes
multiple asexual divisions, resulting in thousands of haploid
sporozoites, which eventually are released from the oocyst into
the circulation. Sporozoites invade the salivary glands after
crossing through the cells in transit to the central ducts of the
gland.
During the insect phase of the Plasmodium life cycle, parasites
must survive for longer than a week in the body of the insect.
Mosquitoes have the ability to mount a strong defense that kills
many parasites, as illustrated by the dramatic increase in number
of parasites when certain antagonistic genes of the mosquito are
silenced through RNA interference [1–3]. By contrast, Plasmodium
interacts with other mosquito proteins in ways that promote
parasite development, since silencing of these genes results in a
reduction in the number of surviving parasites [4–5]. Some of
these positive factors appear to play roles in the formation of the
oocyst [5–6] or in ookinete penetration of the cells [3] while the
function of others is not defined [2]. Both types of regulators of
parasite development offer new targets for malaria control, since
transmission could be blocked by promoting negative regulators or
by interfering with positive interactions.
Lysozymes (EC 3.2.1.17) are antibacterial proteins defined by
their ability to hydrolyze b-1, 4-glycosidic linkage between N-
acetylmuramic acid and N-acetylglucosamine of peptidoglycan in
the cell wall of bacteria. This generally limits direct growth
inhibition to Gram-positive bacteria [7] although there are a
growing number of exceptions [8–10]. In the animal kingdom
three distinct categories of lysozymes have been identified, c-type,
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among animals, with isoforms in taxa ranging from mammals to
arthropods. In mosquitoes as in other dipteran insects, multiple
lysozyme genes exist, only some of which are inducible by
microbial challenge [12–14]. In An. gambiae, the genome encodes
eight c-type lysozyme genes [15]. One of these, lysozyme c-1,
binds to and can protect an abiotic target (CM-Sephadex beads)
from melanization in An. gambiae [16] and is induced upon
bacterial challenge [15,17–18]. Lysozyme c-1 is a typical
antibacterial protein and exhibited muramidase activity against
the Gram-positive bacteria Micrococcus luteus and Bacillus subtilis
[19]. Silencing of LYSC-1 by RNAi resulted in enhanced mortality
in the mosquitoes following bacterial challenge [19].
Here, we report the surprising finding that an Anopheles
gambiae lysozyme acts as a protective agonist for the develop-
ment of Plasmodium oocysts. In the studies presented here,
immunohistochemical analyses and gene silencing confirmed
that physical interaction of lysozyme c-1 with the parasite
surface following the critical period of midgut invasion was
associated with parasite persistence. Identification of this
mosquito protein as a positive agonist for malaria parasite
development – a novel finding for an antibacterial effector
protein – provides a new target for interference with the oocyst
stage of the parasite life cycle.
Results
Lysozyme c-1 binds to oocysts of P. berghei and
P. falciparum
In previous studies we used CM-Sephadex beads as a tool to
study melanization of foreign targets in An. gambiae [16,20–21]. We
discovered that the L3-5 strain of An. gambiae usually melanized
both malaria parasites and CM-Sephadex beads, while a
susceptible strain (4a rr) did not. Beads were protected from
melanization upon transfer from 4a rr to L3-5 females [21]
suggesting that the protective factor was bound to transferred
beads. Lysozyme c-1 was identified in eluates from beads that were
incubated in 4a rr mosquitoes and knockdown of the LYSC-1 gene
in the 4a rr strain restored melanization upon transfer to L3-5
[16]. These studies suggested that physical association of lysozyme
c-1 with developing malaria parasites might protect them from
mosquito defense responses [22].
To investigate whether lysozyme c-1 (GenBank accession
DQ007317) binds to Plasmodium parasites in susceptible mosqui-
toes, we performed immunohistochemical analyses of midgut
tissues from mosquitoes infected with P. berghei or P. falciparum.W e
verified the specificity of anti-lysozyme c-1 antibodies aLys-c-1
9122 and aLys-c-1 9124 (hereafter designated as 9122 and 9124)
against lysozyme c-1 obtained from mosquito salivary glands,
conditioned media of An. gambiae cell line 4a3B and recombinant
lysozyme c-1 produced in E. coli or baculovirus. Via Western
blotting, we confirmed that these antibodies specifically cross-
reacted with a protein approximating the expected molecular
weight of 15 kDa (Figure 1A and 1B) in these samples. A pre-
immune serum from the same rabbit in which lysozyme c-1
antibodies (9122) were raised did not cross-react to lysozyme c-1
from any of the aforementioned sources (Figure 1A and 1B).
Further support for specific binding of these antibodies to
lysozyme c-1 was derived from these observations. First, the
peptide used for generation of 9122 and 9124 antibodies differed
significantly from the sequences of other An. gambiae lysozymes at
these residues but was nearly identical to the orthologous sequence
from An. stephensi (Figure 1C, [10]). Second, antibody 9122 did not
cross-react with partially purified recombinant lysozymes c-2 and
Figure 1. Anti-lysozyme c-1 antibodies 9122 and 9124 specifically recognized lysozyme c-1. (A) Western blot showing cross-reaction of
lysozyme c-1 antibodies with salivary glands from An. gambiae G3 (lane 1 with 9122; lane 2 with 9124), with salivary glands from An. stephensi (lane 3
with 9122) and no cross-reaction of salivary gland extracts with pre-immune serum (lane 4). (B) Western blot showing cross-reaction of 9122
antibodies (lane 1 and 2) or 9124 (lane 3 and 4) or pre-immune serum (lane 5 and 6) with recombinant lysozyme c-1 purified from E. coli (lane 1, 3 and 5)
and from conditioned medium of 4a3B cells (lane 2, 4 and 6). (C) Alignment of the An. gambiae lysozyme c-1 peptide (underlined) used to generate
antibodies with other An. gambiae homologuesandan orthologue from An. stephensi. (D) Coomassiestained gel showing E. coli expressed recombinant
lysozyme c-1 (lane 1); partially purified recombinant lysozyme c-2 (lane 2) and partially purified recombinant lysozyme c-4 (lane 4).
(E) Western blot showing cross-reaction of lysozyme c-1 antibodies (9122) with purified recombinant lysozyme c-1 (lane 1) and absence of cross-
reactivity with partially purified lysozymes c-2 and c-4 (lanes 2 and 4) and serum proteins from mouse (lane MB).
doi:10.1371/journal.pone.0019649.g001
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mouse blood (Figure 1E).
We surveyed over 300 parasites from nine separate infections of
P. berghei in An. gambiae, more than 700 parasites from two
infections of P. falciparum in An. gambiae, and 30 parasites from one
infection of P. falciparum in An. stephensi for lysozyme c-1 labeling
using anti-lysozyme c-1 antibodies. In vivo, some ookinetes showed
a variable degree of labeling but 80–90% ookinetes were not
labeled at 22–24 h (Figure 2A). Similarly, in vitro cultured
ookinetes pre-incubated with recombinant lysozyme c-1 did not
subsequently cross-react with these antibodies. In contrast, the
9122 and 9124 antibodies bound to nearly all oocysts of P. berghei
(Figure 2A) and P. falciparum (Figure 2B) in vivo at 2 days and 5 days
post-infection. Additionally about 12% of P. berghei oocysts counted
from eight infected An. stephensi midguts showed lysozyme c-1
staining at day 15 post-infection (Figure 2D). Among the 15 day
old oocysts that exhibited this lysozyme c-1 signal, some had
lysozyme c-1 around the capsule while others had intense staining
concentrated at one edge of the parasite. No lysozyme c-1 staining
was detected in controls where pre-immune sera were used as the
primary antibody or when primary antibody was omitted
(Figure 2C and 2D lower panels) confirming a specific binding
to lysozyme c-1 on the parasite surface.
We considered the possibility that the antibody might bind to a
vertebrate lysozyme, since the ookinetes first develop in vertebrate
blood within the gut. However, the lysozyme c-1 antibody (9122)
did not cross-react with any mouse serum proteins (Figure 1F, lane
MB) nor did it bind to ookinetes cultured from mouse blood
(results were similar to absence of texas-red signal as presented in
Figure 2, upper left panel).
Lysozyme c-1 is necessary for P. berghei oocyst
development in An. gambiae
Injection of dsRNA into the thorax of female An. gambiae G3
mosquitoes significantly reduced the in vivo expression of LYSC-1 in
all three replicate experiments (2–30 fold; Figure 3). Four days
after dsRNA injection, An. gambiae G3 mosquitoes were allowed to
feed on mice infected with GFP-expressing P. berghei. Infection
levels were scored by counting the number of oocysts per midgut
at 3 days post-infection. In three independent experiments,
knockdown of LYSC-1 significantly reduced prevalence
(Figure 3A) and intensity (Figure 3B) of P. berghei infections. The
reduction in prevalence of infection in LYSC-1 KD mosquitoes
ranged from 33–72% relative to GFP controls. Further, LYSC-1
KD caused a 6.4 fold reduction (p=0.0003) in the average number
of oocysts counted from three separate experiments as compared
to GFP controls. There was no effect on the statistical significance
when we performed analysis on data including all parasite fed
mosquitoes (including zeros) or data omitting uninfected mosqui-
toes (excluding zeros) (Figure 3). Because lysozyme c-1 can protect
Sephadex beads from melanization [11] we also looked for the
Figure 2. Lysozyme c-1 is associated with Plasmodium berghei and Plasmodium falciparum oocysts. Plasmodium berghei parasites were
detected via green fluorescence and anti-lysozyme c-1 antibodies (9122 or 9124 as indicated with white arrows) were detected using Texas-red
secondary antibody. All images were collected using confocal microscopy. Representative images of the P. berghei and P. falciparum parasites
(indicated with white arrows) are shown. (A) Lysozyme c-1 was not detected on early stage ookinetes of P. berghei (22 h, upper left) but was present
on later stages (Days 2 and 5; D2 and D5) of both P. berghei (A, lower left) and P. falciparum oocysts in An. gambiae (B). Pre-immune serum as well as
omitting primary antibody showed no staining of parasites (C) indicating a specific labeling by anti-lysozyme antibody 9122 or 9124. Day 5 parasites
are shown for control antibodies. (D) Staining of P. berghei oocysts with 9122 as well as 9124 antibodies at day 15 post-infection in An. stephensi.
DIC=differential interference contrast; GFP=Green fluorescent protein; Texas red=Goat anti-rabbit secondary antibodies labeled with Texas-red
used to visualize 9122 or 9124 primary antibodies for lysozyme c-1.
doi:10.1371/journal.pone.0019649.g002
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GFP or LYSC-1 KD mosquitoes (Figure 4).
In order to determine whether lysozyme c-1 mediated midgut
invasion or very early oocyst development, we quantified
prevalence and intensity of P. berghei infection in An. gambiae at
24 h post-infection, a time point that corresponds with early
midgut invasion and initial oocyst formation. Neither the
prevalence of infection nor the number of ookinetes per midgut
were statistically different between LYSC-1 and GFP KD groups
[average number of ookinetes in dsLYSC-1 injected (n=17)=110
and dsGFP injected mosquitoes (n=19)=127, T-test p=0.59].
Finally we examined whether lysozyme c-1 would enhance the
viability of cultured ookinetes. A time course of incubation of
cultured ookinetes with in vitro produced lysozyme c-1 showed no
effect on the viability of the ookinetes over a 24 h period. We
found a little change in the number of dead parasites between 2
and 24 h. In the control sample (ookinetes incubated with BSA)
6.3% ookinetes were dead by 24 h compared with 5.1% by 2 h. In
the lysozyme c-1 treated sample 3.85% ookinetes were dead by
24 h as compared with 3.80 by 2 h.
Neither lysozyme c-1 or its muramidase activity were
detected in the midgut tissues
The association of lysozyme c-1 with developing parasites
suggested that this protein could be synthesized or localized to the
midgut, an observation that would have extended previous
identifications of lysozyme c-1 in hemolymph, salivary glands
and hemocytes [16,19,23]. To investigate this possibility, we
examined dissected midguts for lysozyme c-1 protein localization
and muramidase activity. On repeated trials we could neither
detect a lysozyme c-1 signal on midgut Westerns nor any
muramidase activity in midgut extracts (Figure 5). It is possible
that elevated protease activity in the midgut extracts might cause a
rapid proteolysis of this protein. However, inclusion of protease
inhibitors did not improve the results.
Depletion of LYSC-1 via gene silencing did not alter the
overall number of culturable midgut bacteria in
An. gambiae
Lysozyme c-1 is an antibacterial protein and, as such, we
recognized that its silencing could alter the growth of the midgut
microbiota that has been shown to affect Plasmodium success in infected
mosquitoes [18]. To examine this possibility, we tested whether
depletion of LYSC-1 affected midgut bacteria. Silencing of LYSC-1 did
not result in a statistically significant difference in the total numbers of
bacteria between control dsGFP versus dsLYSC-1 groups (Figure 6).
Discussion
The sporogonic development of malaria parasites depends on a
complex interaction with their mosquito hosts. Although lyso-
zymes are well known for their antimicrobial activities, our data
Figure 3. Lysozyme c-1 knockdown (KD) significantly reduced prevalence and intensity of P. berghei infections. The results of three
independent replicate experiments for the An. gambiae G3 strain are shown. (A) Shows the significantly decreased prevalence of infection in the
LYSC-1 KD mosquitoes. Prevalence was defined as the percentage of mosquitoes that had at least one oocyst per mosquito midgut. (B) Oocyst count
data from the three independent replicate experiments including zeros or excluding zeros (mosquitoes that had no infection) is presented. A two-
way ANOVA was conducted on individual experiments and p-values are presented along with mean 6 SE of oocysts counted in each experiment. The
p-value for the totals row indicates the significance of the test when the effect of experiment was included. Parasite numbers were significantly lower
in the LYSC-1 KD mosquitoes as compared to control GFP group.
"Indicates the fold reduction in the expression LYSC-1 as compared to control GFP
groups as determined via densitometry analysis (see Materials and Methods).
doi:10.1371/journal.pone.0019649.g003
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regulator of Plasmodium parasite development. Knockdown of the
LYSC-1 gene significantly reduced the prevalence of P. berghei-
infected An. gambiae as well as the average number of oocysts per
infected midgut. Immunohistochemistry clearly demonstrated that
lysozyme c-1 was associated with oocysts of P. falciparum and P.
berghei in both An. gambiae and An. stephensi. Knockdown of LYSC-1
in An. gambiae mosquitoes did not result in changes in numbers of
viable P. berghei parasites until 3 days post-infection. That is, similar
numbers of fluorescing parasites were seen in control and
Figure 4. Lysozyme c-1 knockdown did not reduce P. berghei oocyst development via increased melanization. Comparison of midguts
infected with a GFP-expressing strain of P. berghei four days after the mosquitoes were injected with either dsGFP or dsLYSC-1. At 3 days post-
infection viable parasites were dramatically reduced (GFP) but parasites did not become melanized (DIC).
doi:10.1371/journal.pone.0019649.g004
Figure 5. Lysozyme c-1 and its muramidase activity were non-detectable in An. gambiae midguts. (A) A representative Western blot
showing an absence of protein cross-reactivity with 9122 antibodies in the midguts as compared to salivary glands. (M=Protein marker).
(B) Turbidometric assay showing absorbance values of different samples subtracted from control (which contained only buffer). Muramidase activity
was non-detectable in the midgut tissues (n=10) as compared to positive control (E.coli produced recombinant lysozyme c-1) as well as salivary
glands (n=10 pairs) 24 h after incubation with Micrococcus lysodeikticus cells.
doi:10.1371/journal.pone.0019649.g005
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formation of ookinetes and invasion of the midgut were similar in
treated and control mosquitoes, and that the block occurred after
oocyst formation. Based on these observations we conclude that
lysozyme c-1 is important to the successful persistence of this
parasite stage.
In addition to lysozyme c-1, other positive regulators of parasite
development have been identified. After ookinetes localize
between the epithelial cells and the midgut basal lamina (BL),
the transition to oocysts occurs. The rapidly expanding oocysts
stretch the overlying layer of the BL at the hemocoelic surface
while a new BL is generated between the oocysts and the epithelial
cells [24]. At the same time, mosquito-derived collagen and
laminin (types of extracellular matrix proteins), are incorporated
into oocyst capsules [2,23,25–26]. Knockdown of laminin mRNA
led to a substantial reduction in the number of successfully
developed oocysts [5]. Laminin has been shown to bind to at least
five P. berghei proteins (P25, P28, SOAP, circumsporozoite and
TRAP-related) in yeast two hybrid assays [24,26–27]. Recently
Nacer et al. [6] convincingly showed that mosquito-produced
laminin indeed becomes part of the parasite capsule during its
passage through the gut.
The acquisition of the basal lamina proteins is likely to help
protect the developing oocysts from the mosquito immune system
and, therefore, may facilitate their prolonged extracellular
development in the mosquito body cavity [25]. Could one of
these protecting proteins be lysozyme? Vertebrate lysozymes bind
to glycosaminoglycans in extracellular matrices [28] and insect
basal laminae are negatively charged [29] which could promote
interaction with the basic lysozyme c-1. Lysozymes have also been
shown to bind and prevent the proteolytic degradation of the
elastin component of elastic fibers in the basal lamina, indicating
that lysozyme interaction can protect elastic fibers at the sites of
injury [30]. Arrighi et al. [5] suggested that the production of new
basal lamina around the midgut may be a normal process
following blood feeding, a process that has been co-opted by the
parasite. Thus, we hypothesize that lysozyme c-1 might associate
with components of the midgut BL and become incorporated
during formation of the BL-related capsule around the parasite.
Our immunohistochemistry data on the interaction of lysozyme
c-1 and malaria oocysts support a direct lysozyme c-1 association
with the parasite. The protein may not originate from the midgut
cells, since we failed to detect the protein in Western blots and
could not detect muramidase activity even after extended
incubation periods of midgut extracts. Ahmed et al. [31] also
failed to detect muramidase activity in midgut extracts following
blood feeding. By contrast we detected lysozyme c-1 in mosquito
hemolymph through Western blotting [16,19] and Ahmed et al.
[31] determined that muramidase activity in the hemolymph
increased following blood feeding. Castillo et al. [23] also
described the occurrence of lysozyme c-1 in hemocytes. These
observations suggest that lysozyme c-1 associated with parasites is
derived from the hemolymph . In studies of the transport of
molecules from the hemolymph across the basal lamina to the
intercellular spaces of the midgut epithelium, other researchers
have shown that cytochrome-c can make this passage [32].
Cytochrome-c is nearly identical to lysozyme c-1 in both size and
charge. Thus, it is entirely possible that lysozyme c-1 can also
move in this direction.
Recent work has described the impact of microbial communities
inhabiting the mosquito midgut on Plasmodium development
[18,33]. We considered the possibility that the antibiotic properties
of lysozyme c-1 might alter the microbial community of the gut
and thereby contribute to the proliferation and protection of P.
berghei parasites in An. gambiae. However, we did not find a
significant change in the numbers of culturable bacteria in control
mosquitoes when compared with mosquitoes depleted of LYSC-1.
This result was not surprising since our previous work demon-
strated that purified lysozyme c-1 had little effect on bacteria
isolated from midguts [19]. This evidence plus the absence of
detectable lysozyme c-1 protein or muramidase activity in the
midguts support the hypothesis that the direct association of
hemolymph-derived lysozyme c-1 and the oocyst is key to the
agonistic interaction. Future studies will investigate the interaction
of malaria parasites and lysozyme c-1 in the light of these findings.
Materials and Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the University of Wisconsin-Madison
Animal Care and Use Committee (ACUC) under the assurance
number A3368-01. All experiments were performed under
anesthesia and all efforts were made to minimize suffering.
Mosquitoes and Plasmodium parasites (P. berghei and
P. falciparum)
Anopheles stephensi and the G3 strain of An. gambiae were used in
P. berghei feeding experiments and mosquitoes were reared as
described previously [34]. Mosquitoes were infected with P. berghei
(ANKA, GFP-labeled; [35]) as previously described [34] and were
maintained at 21uC with 80% humidity to allow parasite
development. Transgenic parasites expressing GFP have been
widely used as a laboratory model to study mosquito-parasite
interactions and have been shown to behave like wild-type
parasites [36]. Anopheles gambiae (Kisumu) and An. stephensi (Indian
wild type) were reared at UC Davis, CA, USA according to
Figure 6. Silencing of LYSC-1 did not alter the overall number of
culturable bacteria in An. gambiae midguts. Enumeration of
culturable bacteria in the midguts of dsGFP and dsLYSC-1 injected
mosquitoes. The presented bacterial count data were derived from
individual mosquitoes from three biological replicates. Statistical
analysis on the count data was performed using software suite R. A
two-way ANOVA analysis on the log-transformed data did not reveal
any statistical significance in the total number of bacteria in the LYSC-1
knockdown mosquitoes as compared to dsGFP injected mosquitoes
(p=0.11).
doi:10.1371/journal.pone.0019649.g006
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falciparum NF54 strain [37]. Mosquitoes infected with P. falciparum
were maintained at 26uC with 80% humidity.
GFP-labeled P. berghei was passaged in Balb/c female mice.
Parasitemia was determined from Giemsa-stained blood smears
and exflagellation was determined with phase contrast microscopy.
For P. berghei, 3–5 day old mosquitoes were fed at parasitemia of 4–
5% and exflagellation rate about 10 exflagellation events in 20
microscopic fields. Mosquitoes were dissected in PBS and
immunohistochemical analysis was performed on midguts as
described below. Mosquito midguts were dissected 22 h (early
stage parasites just started to invade midgut epithelium), 2 and 5
days (during early oocyst satges) and 15 days (during mid to late
oocyst stages) post infection. The luminal contents were removed
in PBS. Morphology of the parasites was examined under the
fluorescent microscope. There is a distinguishable morphological
difference between these ookinete and ooycyst stages of the
parasite. Whereas the ookinetes are elongated or retort in shape,
the oocysts are oval/round. The numbers of ookinetes/oocysts
were counted using a fluorescent microscope (Leica) based on their
morphological difference.
In vitro culturing of P. berghei ookinetes was performed according
to protocol described by Winger et al. [38]. For the assessment of
lysozyme c-1 effect on ookinete viability, the cultured ookinetes
were incubated with in vitro produced lysozyme c-1 (100 mg/ml) or
similar amounts of bovine serum albumin as control for a period of
2–24 h. Ookinete viability was determined via fluorescence
microscopy. Whereas live ookinetes exhibited green fluorescence,
dead parasites did not fluoresce green but were visible under phase
contrast optics.
Synthesis of peptides for antibody production and
Western blotting
To produce antibodies (9122 and 9124) for lysozyme c-1, peptide
sequences for the eight An. gambiae lysozymes were aligned, and a
fragment of 15 amino acids that was largely unique to lysozyme c-1
was identified (Figure 1D). This peptide was synthesized, conjugated
to MAP (a proprietary carrier from Invitrogen, Grand Island, New
York), and used for immunization of rabbits by Invitrogen. Rabbits
were immunized with 0.5 mg synthetic peptide in adjuvant and then
boosted with the same amount of peptide at weeks 2, 7 and 8. Sera
were harvested 10 weeks after initiation of the protocol. Pre-immune
serum was collected before the start of immunization. Western
blotting was performed either as described previously [19] or with
modifications. These modifications included use of primary antibod-
ies,9122 or 9124, wereused at 1:1,000 dilution and detection of these
antibodies with 1:50,000 dilution of peroxidase- labeled goat-anti-
rabbit secondary antibodies using chemiluminiscence substrate
(Perkin Elmer, USA) as per supplied instructions along with the kit.
Recombinant lysozyme c-1 produced in E. coli had a slightly higher
molecular weight as it retains a few additional amino acids from
expression vector (Figure 1B). (Figure 1D). To assess the specificity of
these antibodies, we also tested them against the mouse serum
proteins via Western blotting (Figure 1E, lane MB). The negative
cross-reaction to in vitro cultured ookinetes was also accessed via IHC.
The results of these analyses weresimilar to the lack of red florescence
on the ookinetes as presented in Figure 2A, upper left panel.
Immunohistochemistry (IHC) on dissected mosquito
midguts
Immunostaining was performed according to the protocol
described by Han et al., 2000 [39] with some modifications. Briefly,
midguts from parasite-infected mosquitoes at days 2, 5 and 15 post
infection, were dissected in phosphate-buffered saline (PBS;
130 mM NaCl, 7 mM Na2HPO4, 3 mM NaH2PO4 H2O
pH 7.2). The tissue was fixed in 4% paraformaldehyde,
100 mM PIPES buffer pH 7.4, 2 mM MgSO4 and 1 mM EGTA
for 10 min at room temperature. The midguts were rinsed in PBS,
then permeabilized in PBT (PBS containing 0.1% Triton X-100)
for 5 min. The tissues were blocked in 1% bovine serum albumin
in PBT for 2 h at room temperature and incubated with primary
antibodies (9122 and 9124) at 1:200 dilutions in 1% BSA in PBT
overnight at 4uC. The tissues were washed with PBT three times
10 min each, and then incubated with Texas-red labeled goat anti-
rabbit IgG (Kirkegaard and Perry Labs, Maryland, USA) at 1:100
dilution in 1% BSA prepared in PBT for 2 h at room temperature.
The stained tissues were washed three times in PBT, 10 min each
and analyzed using confocal microscopy (Bio-Rad Radiance 2100
MP Rainbow confocal imaging system; Keck Laboratory for
Biological Imaging, University of Wisconsin) for GFP (for P. berghei)
and Texas-red signals.
dsRNA mediated silencing of LYSC-1 in the An. gambiae
An in vitro transcription template was produced using a one-step
PCR protocol as described previously [19]. The primers used to
prepare the templates for An. gambiae LYSC-1 and exogenous GFP
contained T7 sequences on the 59 ends of the forward and reverse
primers (Fwd 59-TAATACGACTCACTATAGGGATGAAAG-
TGTTTTCCACAGTTTTG -39, Rev 59- TAATACGACTCA-
CTATAGGGAAAAACAGGAGCTAACATTCGG -39). These
primers were used to amplify a product from mosquito cDNA.
The GFP sequence (Fwd: 59-TAATACGACTCACTATAG-
GGCGTGATCAAGCCCGACA-39, Rev: 59-TAATACGACT-
CACTATAGGGCTTCGGCGTGCTC-39) was used to amplify
a product from phMGFP vector (Promega, Madison, Wisconsin).
The choice of GFP as the control is unrelated to its use as a
transgenic marker for the parasite. Injection of dsGFP does not
silence parasite GFP probably because it is introduced well before
the introduction of the parasite. In these experiments, use of the
exogenous, unrelated GFP dsRNA served two purposes 1) as an
injection control to assess the impact of breaching the exoskeleton
of the host on processes that might affect parasite development,
and 2) to assess whether injection of nucleic acids affected process
that might affect development of the parasite. The PCR products
were purified using a QIAquick gel extraction kit (QIAGEN
Sciences, Maryland, USA) and 1–2 mg of the products were used
as templates for transcription. The MEGAscript
TM RNAi kit
(Ambion, Austin, Texas) was used for transcription and the
production of dsRNA following the instruction manual. The
dsRNA concentration was measured using micro-spectrophotom-
etry (Nanodrop NT1000, Thermo Fisher Scientific, Waltham,
MA). dsRNA preparations were checked for integrity on an
agarose gels stained with ethidium bromide. The dsRNA
preparations were stored at 280uC until used.
For introduction of dsRNA for LYSC-1 or control GFP,
newly eclosed female mosquitoes (less than 24 h after eclosion)
were cold anesthetized and injected in the thorax using
calibrated glass needles under a dissecting microscope. The
needles for injections were produced using glass capillary tubes
(Fisher Scientific, USA) pulled with Narishige glass puller
(Narishige International USA, Inc., NY, USA). To assess the
optimal concentration of dsRNA needed to achieve maximal
knockdown of LYSC-1, we carried out pilot experiments with
dsRNA concentration ranging from 0.6–1.4 mga n dd e t e r -
mined that persistent and efficient knockdowns were achieved
with 1.4 mgo fd s R N Ai n0 . 1ml injected volume. The efficiency
of the knockdown was examined using semiquantitative RT-
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of dsRNA and equally efficient KD of LYSC-1 was detected
during these times. We also tested the effect of LYSC-1 KD on
other related lysozymes and did not detect altered expression
for any of these genes (data not shown).
Mosquitoes were infected with P. berghei parasites four days post-
injection of dsRNA-a standard procedure described in literature
[1]. This time period allows females to recover from the injury
caused by the injections. Three independent replicate experiments
were performed. For each experiment, dsGFP and dsLYSC-1
mosquitoes were fed on the same infected mouse for the
assessment of the effect of LYSC-1 silencing on the intensity and
prevalence of infections. Three days post infection the GFP
expressing oocysts were counted from both groups under a
fluorescent microscope. A two way ANOVA test was performed
on the count data from both infected or uninfected mosquitoes
(with or without zeros) to determine the significance of LYSC-1
knockdowns as compared to control GFP groups (Figure 3).
ANOVA did not reveal a significant inter-experimental variation
among the three replicate experiments for zero-included and zero-
excluded data (p.2.0). All analysis were conducted using
SASHv9.3 (SAS Institute, Cary, NC).
Semiquantitative RT-PCR
Semiquantitative RT-PCR was performed to assess relative
transcript abundance in adult female mosquitoes following RNAi.
Total RNA was isolated from five An. gambiae mosquitoes from
respective treatments using MasterPure
TM Complete DNA and
RNA Purification Kit (Epicentre Biotechnologies, Madison, WI,
USA) according to the supplied instructions. Total RNA was
treated with RQ1 DNAse (Promega, Madison, WI) at a
concentration of 1 unit/mg RNA preparation to remove genomic
DNA. RNA concentration was measured with micro-spectropho-
tometry (Nanodrop NT1000, Thermo Fisher Scientific, Waltham,
MA). Five hundred nanograms of total RNA were used to
synthesize cDNA using a High-Capacity cDNA Archive Kit. The
resulting cDNA was stored at 220uC until use. Primers based on
An. gambiae cDNA sequences for LYSC-1 (GenBank: accession
no. DQ007317) and RPS7 [40] were designed using Oligoperfect
software (Invitrogen). The S7 ribosomal gene was used to
normalize the template taken for PCR. Final concentrations of
reagents used for RT-PCR were 16 buffer, 200 mM dNTPs,
0.5 mM each primer, 0.2 ml (4 units) Advantage Taq polymerase
(Clontech Laboratories Inc., CA, USA). PCR cycle conditions
were: an initial denaturation at 95uC for 3 min; then repeated
cycles of 95uC for 30 s, 60uC for 30 s, 72uC for 30 s; and a final
extension step at 72uC for 10 min. For LYSC-1, 35 cycles were
used while 25 cycles were used for S7. PCR products were
separated on 1% agarose gels and stained with ethidium bromide.
The gels were exposed to UV-transillumination and images were
captured on a gel-imaging system. Signal intensities of RT-PCR
bands in the KD experiments were quantified by densitometeric
analysis using the Quantity One Software (version 4.6.8) from Bio-
Rad Laboratories (Bio-Rad, Hercules, CA). Fold change in
expression was calculated by dividing the ratios of GFP/S7 control
with LYSC-1/S7 KD signals (Figure 3B).
Lysozyme c-1 activity assays
Muramidase activity assays with purified lysozyme c-1 or
midgut extracts were performed as described in [19]. Briefly, ten
midguts were homogenized in 20 mM HEPES, pH 7.5. The gut
extract was incubated at room temperature on a rotator shaker
with 0.5 mg/ml Micrococcus lysodeikticus cells prepared in same
buffer for 24 h. Muramidase activity was recorded as reduction in
the absorbance measured at 450 nm and compared to positive
control (purified lysozyme c-1) or with negative control (20 mM
HEPES, pH 7.5 buffer).
Enumeration of bacteria in midguts of LYSC-1 silenced
An. gambiae mosquitoes
Silencing of LYSC-1 was carried out as described above. For
these experiments, mosquitoes from dsLYSC-1 (n=23) or dsGFP
(n=19) injected groups were harvested after four days post
injection. Individual mosquito midguts were dissected under
sterile conditions as described in [28]. Midgut extracts were
serially diluted in 0.9% NaCl and plated on tryptic soy agar
(TSA) plates. Bacterial colony forming units (CFUs) in the
range of 30–300/plate were counted after 48 h incubation at
28uC. Three independent experiments were performed and
CFUs from individual mosquitoes were averaged across the
replicates. Statistical analysis on the count data was performed
using software suite R. We performed two-way ANOVA on
both raw and log-transformed count data. It was necessary to
transform the data to obtain adequate normality as we found a
great variation in the number of culturable bacterial CFUs
from individual mosquitoes within one experimental replicate
as well as among three experiments that skewed the normality.
A two-way ANOVA analysis on the log-transformed data did
not reveal any statistically significant difference among the
total number of bacteria between control dsGFP and dsLYSC-1
injected mosquitoes (p=0.11).
Sources and expression of lysozymes c-1, c-2 and c-4
Lysozyme c-1 was purified either from conditioned media of
4a3B cells as described in [19] or was cloned into a proprietary
cloning vector pVP68K (a gift from Dave Aceti, Center for
Structural Genomics, UW Madison) and expressed in vitro in E. coli
BL21(DE3) cells according to standard procedures. Lysozyme c-1
is produced as a fusion protein along with histidine and maltose
binding protein (MBP) tags. The lysozyme c-1- MBP-His8 –fusion
protein was purified via amylose affinity columns (New England
Biolabs, MA, USA). Purified lysozyme c-1- MBP-His8 –fusion was
cleaved with 3C protease (Novagen, USA) to remove MBP
(maltose binding protein). The cleavage reaction resulted in the
precipitation of lysozyme c-1. The precipitated lysozyme c-1 was
then denatured in 4M GdHCl and refolded in a buffer containing
HEPES-50 mM, NaCl-250 mM, Glycerol-10%, GSH-30 mM,
GSSG-5 mM, final pH adjusted to 8.0. The refolded and
enzymatically active lysozyme c-1 was further purified to
homogeneity via ion exchange chromatography on CM-Sephadex
C-25 beads (Figure 1D). Recombinant lysozyme c-2 and c-4 were
generated and partially purified on amylose resin using the same
bacterial expression system.
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